Quantcast
Researchers Explore The Relationship Between Weight And

Researchers Explore The Relationship Between Weight And Stress-Induced Inflammation

Brandeis University If you're overweight, you may be at greater risk for stress-related diseases like type 2 diabetes, cardiovascular disease and cancer, according to a new study by Brandeis University. It's long known that psychological...

Latest inflammation Stories

2014-09-26 23:00:20

Treatment designed to reduce pain and inflammation associated with radiation therapy to the lower bowel. Claremont, CA (PRWEB) September 27, 2014 Synedgen announced today the award of a competitive Small Business Innovation Research (SBIR) Phase I contract from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to demonstrate proof-of-concept activity of Synedgen’s proprietary treatment for radiation proctitis, a condition that causes painful tissue damage to...

2014-09-24 23:12:05

Novera Fitness, an athletic and recovery center based in Golden, has announced that they will be bringing the innovative cryosauna to Colorado. The cryosauna has been used for recovery by athletes for years, and uses air cooled to -190ºF or more to decrease inflammation and pain while supercharging blood to promote faster healing and recovery. Denver, Colorado (PRWEB) September 24, 2014 Novera Fitness, an athletic and recovery center based in Golden, is bringing the state-of-the-art...

2014-09-19 08:26:16

SAN FRANCISCO, Sept. 19, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) today announced results from preclinical studies characterizing the analgesic profiles of a series of the company's internally-discovered oral, peripherally-acting kappa opioid receptor agonist molecules. The preclinical research candidates were created using Nektar's small molecule polymer medicinal chemistry platform. The analgesic properties of kappa receptor agonism are well described in the medical...

2014-09-19 08:25:40

PRINCETON, N.J., Sept. 19, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has been awarded a contract valued at up to $24.7 million inclusive of options by the US Department of Health and Human Service's National Institutes of Health (NIH) (specifically funded by the National Institute...

2014-09-18 08:30:19

- Richards Teams Up with Allergan, the Makers of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%, to Raise Awareness of the Disease - IRVINE, Calif., Sept. 18, 2014 /PRNewswire/ -- TV personality, fashion entrepreneur and star of the "Real Housewives of Beverly Hills" Kyle Richards is partnering with Allergan, the makers of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%, to raise awareness of Chronic Dry Eye. As many as 25 million people in the United States report suffering...

2014-09-18 08:28:52

MONMOUTH JUNCTION, N.J., Sept. 18, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using its CytoSorb® blood purification technology to treat life-threatening inflammatory conditions such as sepsis, is a proud sponsor of: -- World Sepsis Day 2014 organized by the Global Sepsis Alliance -- The short film "97 seconds for sepsis" produced by the Global Sepsis Alliance -- The 3(rd) Annual Celebration of Sepsis Heroes...

2014-09-17 08:28:52

Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that agreement has been reached with the US Food and Drug Administration (FDA) on the design of a pivotal, Phase 3 clinical trial evaluating its...

2014-09-11 12:27:04

SARASOTA, Fla., Sept. 11, 2014 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that the United States Patent and Trademark Office has issued a 'Notice of Allowance' for patent application 11/673,486 entitled 'Oligonucleotide-Containing Pharmacological Compositions And Their Uses'. The '486 patent application relates to the Company's orally-deliverable nanoRNA therapeutics that act through gene-silencing and can be...

2014-09-09 08:31:27

MONMOUTH JUNCTION, N.J., Sept. 9, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a blood purification company using its CytoSorb® extracorporeal cytokine adsorber to prevent or treat organ failure in life-threatening conditions, announced its U.S. Cardiac Surgery Advisory Board (CSAB) that includes leaders in cardiothoracic surgery, surgical critical care, extracorporeal therapy, and inflammation. The Board will oversee the use of CytoSorb® in cardiac surgery trials...

macrophages engulf dead cells
2014-09-08 02:00:50

Salk Institute Salk scientists identify how immune cells use two critical receptors to clear dead cells from the body, pointing the way to new autoimmune and cancer therapies. In most of the tissues of the body, specialized immune cells are entrusted with the task of engulfing the billions of dead cells that are generated every day. When these garbage disposals don’t do their job, dead cells and their waste products rapidly pile up, destroying healthy tissue and leading to autoimmune...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related